ViiV Healthcare – Product Pipeline Review – Q1 2011
Reference Code: GMDHC1085CDB
Publication Date: MAR 2011
ViiV Healthcare – Product Pipeline Review – Q1 2011 GMDHC1085CDB / Published MAR 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied Page(1)
ViiV Healthcare – Product Pipeline Review
Ta b le o f Co n te n ts
Table of Contents 2
List of Tables 4
List of Figures 4
ViiV Healthcare Snapshot 5
ViiV Healthcare Overview 5
Key Information 5
Key Facts 5
ViiV Healthcare – Research and Development Overview 6
Key Therapeutic Areas 6
ViiV Healthcare – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
ViiV Healthcare – Pipeline Products Glance 10
ViiV Healthcare – Late Stage Pipeline 10
Phase III Products/Combination Treatment Modalities 10
ViiV Healthcare Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
ViiV Healthcare – Drug Profiles 13
1349572 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
572-Trii 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Research and Development Brief 14
PF-232798 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
S/GSK1265744 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
UK-453061 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
PF-3716539 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
ViiV Healthcare – Pipeline Analysis 20
ViiV Healthcare – Pipeline Products by Therapeutic Class 20
ViiV Healthcare – Product Pipeline Review – Q1 2011 GMDHC1085CDB / Published MAR 2011
©Global Markets Direct.. This report is a licensed product and is not to be photocopied Page(2)
ViiV Healthcare – Product Pipeline Review
ViiV Healthcare - Pipeline Products By Target 21
ViiV Healthcare – Pipeline Products by Route of Administration 22
ViiV Healthcare – Pipeline Products by Molecule Type 23
ViiV Healthcare – Recent Pipeline Updates